Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8957033
Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof
granted -
US 8957066
Histone deacetylase inhibitors
granted -
US 8951998
Quinoxaline-containing compounds as hepatitis C virus inhibitors
granted -
US 8951964
Phenanthridine macrocyclic hepatitis C serine protease inhibitors
granted -
US 8940688
Fluorinated tripeptide HCV serine protease inhibitors
granted -
US 8940773
Prolyl hydroxylase inhibitors and methods of use
granted -
AU 2013283318
Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders
granted -
US 8936781
Macrocyclic compounds as hepatitis C virus inhibitors
granted -
US 8937093
Heterocyclic aspartyl protease inhibitors
granted -
US 8937064
Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors
granted -
US 8933110
Hepatitis C virus inhibitors
granted -
US 8933080
Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
granted -
US 8933201
Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
granted -
US 8927709
Hepatitis C virus inhibitors
granted -
US 8927730
Intramolecular hydrogen-bonded nitric oxide synthase inhibitors
granted -
US 8927576
HCV inhibitor and therapeutic agent combinations
granted -
US 8921358
Apoptosis signal-regulating kinase 1 inhibitors
granted -
US 8921372
Inhibitors of hepatitis C virus
granted -
US 8921376
Pyrrolopyridines useful as inhibitors of protein kinase
granted -
US 8921371
Oligomer-protein tyrosine kinase inhibitor conjugates
granted -
US 2014378455
NEW USE OF 1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 BETA INHIBITORS
granted -
US 8916566
Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
granted -
US 8916596
Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor
granted -
US 8916519
Influenza A virus vaccines and inhibitors
granted